Ed Kuijper
Overview
Explore the profile of Ed Kuijper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
1332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Davido B, Merrick B, Kuijper E, Benech N, Biehl L, Corcione S
Lancet Microbe
. 2025 Feb;
:101063.
PMID: 39983749
The rise of antimicrobial resistance presents a challenge to public health, undermines the efficacy of antibiotics, and compromises the management of infectious diseases. Gut colonisation by multidrug-resistant organisms, such as...
2.
Joshi L, Michell S, Kuijper E
J Med Microbiol
. 2024 Aug;
73(8).
PMID: 39162701
No abstract available.
3.
Karampatakis T, Kandilioti E, Katsifa H, Nikopoulou A, Harmanus C, Tsergouli K, et al.
Future Microbiol
. 2024 Jun;
19(13):1119-1127.
PMID: 38913938
The aim was to highlight the incidence and epidemiology of infections (CDI) in a tertiary Greek hospital during the COVID-19 pandemic. A single-center prospective observational cohort study was conducted (October...
4.
Benech N, Barbut F, Fitzpatrick F, Krutova M, Davies K, Druart C, et al.
Clin Microbiol Infect
. 2023 Dec;
30(4):462-468.
PMID: 38101472
Background: Faecal microbiota transplantation (FMT) is the standard treatment for patients with multiple recurrent Clostridioides difficile infection (rCDI). Recently, new commercially developed human microbiota-derived medicinal products have been evaluated and...
5.
Krutova M, Wilcox M, Kuijper E
Int J Infect Dis
. 2022 Sep;
124:118-123.
PMID: 36155825
Recently, the recommendations for the treatment of Clostridioides difficile infection (CDI) have been updated. However, in addition to the clinical efficacy data, the drug of choice should ideally represent optimal...
6.
Aptekorz M, Sacha K, Gofron Z, Kabala M, Harmanus C, Kuijper E, et al.
Pathogens
. 2022 Aug;
11(8).
PMID: 36015069
Clostridioides difficile is an important health care-associated pathogen. The aim of this study was to analyze the antibiotic susceptibility of C. difficile isolates from feces of patients from 13 hospitals...
7.
Fliss M, van den Berg C, Kuijper E, Notermans D, Hendrickx A, Schoots M, et al.
Eur J Clin Microbiol Infect Dis
. 2022 Jul;
41(8):1133-1138.
PMID: 35790590
Infections with hypervirulent Klebsiella pneumoniae (hvKp) commonly presents with primary liver infection, bacteremia, and metastatic abscesses. Here, we present 2 cases of severe community-acquired pulmonary infections by hvKp in patients...
8.
Kachrimanidou M, Metallidis S, Tsachouridou O, Harmanus C, Lola V, Protonotariou E, et al.
Anaerobe
. 2022 Jun;
76:102601.
PMID: 35688364
Objectives: The epidemiology of Clostridioides difficile infection (CDI) has undergone many changes since the beginning of this century and continues to evolve based on recent studies. Here, we performed a...
9.
Fisher M, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell E, Bowyer P, et al.
Nat Rev Microbiol
. 2022 Mar;
20(9):557-571.
PMID: 35352028
Invasive fungal infections pose an important threat to public health and are an under-recognized component of antimicrobial resistance, an emerging crisis worldwide. Across a period of profound global environmental change...
10.
Kabala M, Gofron Z, Aptekorz M, Sacha K, Harmanus C, Kuijper E, et al.
Infect Drug Resist
. 2021 Aug;
14:3247-3254.
PMID: 34429622
Objective: The aim of this study was outbreak investigation due to the emergence of rifampicin resistant ribotype 027 (RT 027) fecal isolates from patients of Polish tertiary care hospital between...